XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plans and Employee Stock Purchase Plan (Tables)
 9 Months Ended
Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity
The following table summarizes stock option activity for the nine months ended October 31, 2023 (in thousands, except share and per share data and years):
Shares
Weighted-Average
Exercise
Price Per Share
Weighted- Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance - January 31, 2023
1,789,813 $7.60 3.3$313,980 
Stock options exercised(659,091)7.31 
Stock options forfeited and expired
(547)5.81 
Balance - October 31, 2023
1,130,175 $7.78 2.7$380,657 
Vested and exercisable - January 31, 2023
1,789,813 $7.60 3.3$313,980 
Vested and exercisable - October 31, 2023
1,130,175 $7.78 2.7$380,657 
Schedule of restricted stock unit activity
The following table summarizes RSU activity for the nine months ended October 31, 2023:
Shares
Weighted-Average Grant Date Fair Value per RSU
Unvested - January 31, 2023
3,480,206 $288.58 
RSUs granted1,922,364 240.62 
RSUs vested(1,256,300)254.88 
RSUs forfeited and canceled(410,853)294.93 
Unvested - October 31, 2023
3,735,417 $286.22 
Schedule of stock-based compensation expense recognized in consolidated statements of operations
Total stock-based compensation expense recognized in the Company’s unaudited condensed consolidated statements of operations is as follows (in thousands):
Three Months Ended October 31,Nine Months Ended October 31,
2023202220232022
Cost of revenue—subscription
$6,018 $5,016 $17,607 $14,492 
Cost of revenue—services
3,200 2,827 9,490 7,599 
Sales and marketing
40,585 38,352 118,567 104,539 
Research and development
50,759 41,458 143,238 117,583 
General and administrative
15,267 11,545 44,194 35,105 
Total stock-based compensation expense
$115,829 $99,198 $333,096 $279,318